A batch of 24 LCDs (most of them being re-released in comment for the benefit of JJ stakeholders) are open for discussion at March 26 and 29 public meetings.
Homepages for the two meetings are here. You can click through to to LCD lists. I've also clipped the LCD list below the break.
Columbia SC March 26
https://www.palmettogba.com/event/pgbaevent.nsf/EventDetails.xsp?EventID=AVQSK98322
Nashville TN March 29
https://www.palmettogba.com/event/pgbaevent.nsf/EventDetails.xsp?EventID=AVQSUB7560
(Cut from Palmetto website html:)
LCDs out for comment are:
- GlycoMark Testing for Glycemic Control DL36761
- Helicobacter Pylori Infection Testing DL37592
- In Vitro Chemosensitivity & Chemoresistance Assays DL34554
- MolDX: Breast Cancer Index℠
- Genetic Assay DL35631
- MolDX: Circulating Tumor Cell Marker Assays DL35071
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Advanced Primary Peritoneal, Fallopian Tube and Ovarian Cancer DL37723
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Colorectal Cancer DL37719
- MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Melanoma DL37721
- MolDX: ConfirmMDx Epigenetic Molecular Assay DL35632
- MolDX: Corus® CAD Assay DL37612
- MolDX: Cystatin C Measurement DL37581
- MolDX: Decipher® Prostate Cancer Classifier Assay DL35868
- MolDX: DecisionDx-Melanoma DL37725
- MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) DL37709
- MolDX: GeneSight® Assay for Refractory Depression DL35633
- MolDX: Genetic Testing for Lynch Syndrome DL35024
- MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) DL37699
- MolDX: MDS FISH DL37602
- MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels DL37713
- MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) DL37701
- MolDX: Pigmented Lesion Assay (PLA) DL37715
- MolDX: Prolaris™ Prostate Cancer Genomic Assay DL35869
- MolDX: ProMark Risk Score DL36665